Tirzepatide's Skin Effects: Injection Reactions, Potential for Psoriasis Treatment, and Facial Aging Concerns
Tirzepatide causes injection-site reactions and rare skin adverse events, but its immunomodulatory properties show potential for treating inflammatory skin diseases like psoriasis and hidradenitis suppurativa.
Quick Facts
What This Study Found
Tirzepatide causes injection-site reactions comparable to semaglutide, rare severe dermatologic events, and facial volume loss from rapid weight loss, but shows immunomodulatory potential for inflammatory skin diseases.
Key Numbers
How They Did This
Narrative review of SURPASS clinical trials, case reports, pharmacovigilance data (PubMed, Scopus, Google Scholar through May 2025) focusing on dermatologic effects.
Why This Research Matters
As millions take tirzepatide, understanding its skin effects—both adverse and potentially therapeutic—helps dermatologists, prescribers, and patients make informed decisions.
The Bigger Picture
The skin effects of GLP-1/GIP drugs are an emerging area as use expands. The dual therapeutic/adverse skin profile mirrors the broader pattern of GLP-1 drug pleiotropic effects.
What This Study Doesn't Tell Us
Therapeutic skin benefits based on case reports only. Cosmetic effects are subjective. Pharmacovigilance data may underrepresent events.
Questions This Raises
- ?Should dermatologists actively investigate tirzepatide for psoriasis in clinical trials?
- ?Can cosmetic interventions (fillers) safely address tirzepatide-induced facial volume loss?
- ?Do skin adverse events differ between branded and compounded tirzepatide?
Trust & Context
- Key Stat:
- Dual skin impact Tirzepatide causes skin adverse events but may also treat inflammatory skin diseases through immunomodulation
- Evidence Grade:
- Review of clinical trial safety data and case reports. Safety data well-established; therapeutic skin benefits are preliminary.
- Study Age:
- Published in 2025.
- Original Title:
- Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review.
- Published In:
- Anais brasileiros de dermatologia, 101(1), 501255 (2026)
- Authors:
- El-Amawy, Heba Saed
- Database ID:
- RPEP-15137
Evidence Hierarchy
Frequently Asked Questions
Does tirzepatide cause skin problems?
Injection-site reactions are the most common skin effect. Rare cases of more serious skin reactions have been reported. The rapid weight loss can also cause facial volume loss and premature aging appearance.
Could tirzepatide treat skin conditions?
Early case reports suggest it may help psoriasis and hidradenitis suppurativa through its anti-inflammatory effects. However, clinical trials are needed to confirm these potential benefits.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15137APA
El-Amawy, Heba Saed. (2026). Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review.. Anais brasileiros de dermatologia, 101(1), 501255. https://doi.org/10.1016/j.abd.2025.501255
MLA
El-Amawy, Heba Saed. "Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review.." Anais brasileiros de dermatologia, 2026. https://doi.org/10.1016/j.abd.2025.501255
RethinkPeptides
RethinkPeptides Research Database. "Tirzepatide in dermatology: cutaneous adverse events, emergi..." RPEP-15137. Retrieved from https://rethinkpeptides.com/research/el-amawy-2026-tirzepatide-in-dermatology-cutaneous
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.